Insulin is the most effective glucose-lowering agent; however, since increased risk of hypoglycemia, weight gain, and fear or unwillingness to inject limits optimization of the dose and number of insulin injections, many patients treated with insulin still do not achieve their glycemic goal[2–4]. Here, INS is linked to Hypoglycemia.